Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. KMB
KMB logo

KMB Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Kimberly-Clark Corp (KMB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
95.040
1 Day change
-2.51%
52 Week Range
144.310
Analysis Updated At
2026/05/29
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

KMB is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock is near the $100 area with slightly positive pre-market action, but the technical setup is mixed, analyst sentiment is mostly Neutral/Hold with recent target cuts, insider selling is elevated, and the short-term pattern points to weakness. The business remains stable and cash-generative, but based on the current data I would not buy aggressively at this price; I would hold and wait for a better entry.

Technical Analysis

KMB is trading in pre-market at 100.36, just above the pivot level of 98.49 and close to resistance at 100.96. MACD is positive and expanding, which supports near-term momentum, but RSI_6 at 71.95 suggests the stock is already stretched in the short term. Moving averages are converging, which typically signals a lack of strong trend conviction. The pattern-based forecast is also negative, with a 60% chance of downside over the next day, week, and month. Overall, the trend is mildly constructive but not an ideal entry for an impatient buyer.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is mildly bullish. The put-call ratios are low, showing more call activity than put activity, and daily option volume is running above the 30-day average. Implied volatility is moderate, with IV percentile at 43.25 and IV rank at 40.72, so the market is not pricing in extreme uncertainty. This supports a cautiously positive sentiment, but it is not strong enough to override the weaker analyst and insider signals.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
12
Buy
3

Positive Catalysts

    • Q1 2026 net sales rose 2.7% year over year to $4.2 billion.
    • Adjusted operating profit increased 3.7% to $732 million.
    • The company reaffirmed 2026 outlook and expects organic sales growth in line with or above category averages.
    • Forward P/E of 13.2x is relatively attractive versus peers and sector averages.
    • Options sentiment leans bullish, with low put-call ratios.

Neutral/Negative Catalysts

    • Analysts have been cutting price targets across the board, reflecting caution on input costs and margins.

Financial Performance

Latest quarter: Q1 2026. Kimberly-Clark showed improving revenue and profit trends in the quarter, with sales up 2.7% to $4.2 billion and adjusted operating profit up 3.7% to $732 million, indicating solid cost control. However, adjusted EPS from continuing operations fell 1.2%, and FY 2025 revenue was down versus the prior year, so growth is positive but not strong enough to call it a clear acceleration. The company appears stable, but earnings power is still under pressure.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is mostly Neutral to Hold. UBS recently raised its target to $106 from $105 but kept Neutral, while Barclays cut its target to $99 and kept Equal Weight. Deutsche Bank also lowered targets and stayed Hold, Wells Fargo reduced its target to $100, and BofA cut its target to $120 from $130 despite a Buy rating. The trend is clearly toward lower targets and caution, with only a few relatively constructive views. Wall Street’s pros: defensive business, attractive valuation, stable demand. Cons: higher input costs, margin pressure, and limited upside conviction.

Wall Street analysts forecast KMB stock price to rise
14 Analyst Rating
Wall Street analysts forecast KMB stock price to rise
5 Buy
8 Hold
1 Sell
Moderate Buy
Current: 97.490
sliders
Low
95
Averages
127.71
High
162
Current: 97.490
sliders
Low
95
Averages
127.71
High
162
UBS
Neutral
maintain
$105 -> $106
AI Analysis
2026-04-29
Reason
UBS
Price Target
$105 -> $106
AI Analysis
2026-04-29
maintain
Neutral
Reason
UBS raised the firm's price target on Kimberly-Clark to $106 from $105 and keeps a Neutral rating on the shares. Kimberly-Clark posted a "decent" start to 2026, but the path forward is still uncertain, the analyst tells investors in a research note.
Barclays
Lauren Lieberman
Equal Weight
downgrade
$105 -> $99
2026-04-14
Reason
Barclays
Lauren Lieberman
Price Target
$105 -> $99
2026-04-14
downgrade
Equal Weight
Reason
Barclays analyst Lauren Lieberman lowered the firm's price target on Kimberly-Clark to $99 from $105 and keeps an Equal Weight rating on the shares. The firm adjusted targets in the consumer staples group as part of a Q1 preview. Barclays has "growing caution" on the group into the prints due to higher input costs. In food, there are now "building concerns" around the sustainability of the dividend for certain companies, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for KMB
Unlock Now

People Also Watch